Trial intelligence / Profile preview

Anesthetic Regimens and Myocardial Injury in OPCAB

NCT02499445Completed

Sponsor
Konkuk University Medical Center
Start
Nov 2007
Primary completion
Oct 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of remifentanil in ischemic heart disease (IHD) (3 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Troponin I. Started Nov 2007; status: completed.

02

Drugs

remifentanil
03

Conditions

ischemic heart disease (IHD)

Beyond the preview

Go deeper on NCT02499445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02499445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call